NEU neuren pharmaceuticals limited

NEU is materially undervalued, page-22

  1. 6,555 Posts.
    lightbulb Created with Sketch. 1857
    Yes Tommy, the FACTS you state are perhaps good reason to keep forecasts and SP expectations very (very) conservative. Invested self interest is not a good predictor of outcome in the speculative share market - experience over the past 12 years has taught me that. Beware of consistent 'pumpers'. OK to hope, futile to rely on it.

    IMO, the only shortish term driver of significant SP gains is BP competition for a takeover, based on their longer term risk acceptance of the 'platform' technology delivering.

    If it is decided to go it alone through at least one P3, then the best consistent SP appreciation scenario will only be market acceptance of that same risk. Instos and retails with a longer term outlook will have to stymie the influence of illiquid algo driven push down.

    My opinion is that there will be a takeover if the price is right, but that price may not please the typical HC investor. A large proportion of the shares are held by investors and management who are sitting on significant paper profits already, that have taken many years to come to fruition. A further decent percentage increase in those profits may be all that is needed to cash in the chips.

    We shall see.




 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.31
Change
0.770(6.14%)
Mkt cap ! $1.655B
Open High Low Value Volume
$12.96 $14.00 $12.91 $19.76M 1.453M

Buyers (Bids)

No. Vol. Price($)
1 3000 $13.30
 

Sellers (Offers)

Price($) Vol. No.
$13.33 3716 1
View Market Depth
Last trade - 16.10pm 26/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.